EMPLOYMENT AGREEMENTEmployment Agreement • November 2nd, 2018 • Newlink Genetics Corp • Pharmaceutical preparations • Iowa
This Employment Agreement (the “Agreement”) is made as of this 26th day of July, 2018, by and between NewLink Genetics Corporation (the “Company”), and Lori Lawley (“Executive”) (collectively, the “Parties”, each a “Party”).
July 26, 2018 Brian Wiley Re: Separation and Release Agreement Dear Brian:Separation and Release Agreement • November 2nd, 2018 • Newlink Genetics Corp • Pharmaceutical preparations • Iowa
This letter sets forth the terms of the separation agreement (the “Agreement”) that NewLink Genetics Corporation (the “Company”) is offering to aid in your employment transition.
July 26, 2018 John B. Henneman, III Re: Separation and Release Agreement Dear Jack:Separation and Release Agreement • November 2nd, 2018 • Newlink Genetics Corp • Pharmaceutical preparations • Iowa
This letter sets forth the terms of the separation agreement (the “Agreement”) that NewLink Genetics Corporation (the “Company”) is offering to aid in your employment transition.
AMENDMENT 3 TO LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 2nd, 2018 • Newlink Genetics Corp • Pharmaceutical preparations • New York
This third Amendment (this “Amendment 3”) is effective as of the last date of signature (the “Amendment Effective Date”), and is entered into by and between MERCK SHARP & DOHME CORP., a corporation organized and existing under the laws of New Jersey (“Merck”), and BIOPROTECTION SYSTEMS CORPORATION, a corporation organized and existing under the laws of Delaware (“NewLink”) and a wholly owned subsidiary of NEWLINK GENETICS CORPORATION, a corporation organized and existing under the laws of Delaware (“NL”).
